Copyright
©The Author(s) 2022.
World J Clin Cases. May 6, 2022; 10(13): 4145-4152
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4145
Published online May 6, 2022. doi: 10.12998/wjcc.v10.i13.4145
No. | Ref. | Age | Symptoms | PSA (ng/mL) | Size (cm) | Immunohistochemistry (positive) | Molecular studies | Treatment | Follow-up (mo) | Metastases |
1 | Colecchia et al[1], 2003 | 31 | NA | 2.06 | 7 | CD99, vimentin, NSE, synaptophysin | EWS/FLI1 fusion | CT, RT, SR | NA | NA |
2 | Peyromaure et al[21], 2003 | 27 | Dysuria and pelvic discomfort | NA | NA | CD99 | t (11; 22) (q24; q12) | CT, SR, RT | 2+ | NA |
3 | Thete et al[10], 2007 | 26 | Dysuria and pelvic discomfort | 0.3 | NA | CD99(Mic-2) | NA | NA | NA | NA |
4 | Kumar et al[16], 2008 | 25 | Burning micturition and dysuria | 0.88 | 6.7 | CD99, vimentin, S100, NSE, synaptophysin | NA | CT | NA | NA |
5 | Funahashi et al[13], 2009 | 20 | Gross hematuria and miction pain | 0.7 | 10 | CD99, NSE, CD56, MIB-1, p53 | t (11; 22) (q24; q12) | SR | 10+ | Lung |
6 | Mohsin et al[14], 2011 | 29 | Burning micturition and urinary retention | 1.3 | NA | CD99 | NA | CT | 4 | Lung |
7 | Al Haddabi et al[4], 2012 | 24 | Dysuria, constipation, back pain, and pelvic discomfort | 0.7 | 10 | CD99, Bcl2, CK19, AE1/AE3, CK, vimentin | Rearrangement of chromosome 22 | CT | NA | No |
8 | Wu et al[5], 2013 | 29 | Difficult defecation and anus distention | 1.19 | 7.4 | CD99, Bcl-2 | NA | SR, CT | 12+ | Lung |
9 | Liao et al[17], 2015 | 49 | Frequent urination, dysuria, and pelvic discomfort | NA | 7.1 | CD99, CD56, NSE, Ki-67 | NA | CT, RT | 24+ | No |
10 | Shibuya et al[3], 2015 | 23 | Dysuria and anal pain | NA | NA | MIC-2, cytokeratin, vimentin, N-CAM | Translocation at chromosome 22q12 | CT | 4 | Bone, lung, meninge |
11 | Esch et al[11], 2016 | 33 | Pelvic pain, dysuria, and urgency | NA | 6 | Cytokeratin | EWSR1-gene | SR | 12+ | No |
12 | Kord et al[8], 2018 | 38 | Abdominal pain, constipation, pain with defecation, and hematuria | NA | 14.4 | CD99 | EWSR1/FLI1 fusion | CT, SR | 14 | Lung, liver, peritoneum |
13 | Du et al[9], 2019 | 39 | Notalgia and paraplegia | 1.07 | 2.6 | CD99, CD56, P63, vimentin | NA | RT, CT | 17 | Thoracic spine |
14 | Javanmard et al[22], 2019 | 37 | Painless gross hematuria | 1.07 | 8.6 | CD99, vimentin, BCL2, Ki67 | NA | SR, CT | 16 | Yes |
15 | Liu et al[23], 2020 | 40 | Dysuria | NA | 11.2 | CD99, synaptophysin, CD56, vimentin | FLI1 | SR, CT | 14+ | No |
16 | Teng et al[15], 2020 | 27 | Dysuria and dyschezia | 1.52 | 8.4 | CD99, CD56, desmin, vimentin | NA | SR | 5 | Lung and peritoneum |
17 | da Ponte et al[12], 2021 | 29 | Pelvic discomfort and dysuria | 0.4 | 8.8 | CD99/MIC-2, synaptophysin | EWS gene rearrangement | CT, SR | 84+ | No |
18 | Present case | 58 | Dysuria, constipation, and pain with defecation | 0.82 | 10.8 | CD99, vimentin, synaptophysin | NA | SR, CT | 34+ | No |
- Citation: Tian DW, Wang XC, Zhang H, Tan Y. Primitive neuroectodermal tumor of the prostate in a 58-year-old man: A case report. World J Clin Cases 2022; 10(13): 4145-4152
- URL: https://www.wjgnet.com/2307-8960/full/v10/i13/4145.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i13.4145